News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

December 3, 2024

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 3rd December 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall have four members, in accordance with the applicable instructions resolved by the Annual General Meeting 2020. The three largest shareholders who are registered with Euroclear Sweden AB on…

March 26, 2024

Lipidor completes planned divestment of shares in Emollivet

STOCKHOLM, Sweden, 26th March 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the remaining holding of…

March 21, 2024

Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2

STOCKHOLM, Sweden, 21st March 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announced that the company's planned Phase…

March 6, 2024

Lipidor adds capital through sale of shares

STOCKHOLM, Sweden, 6th March 2024 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces that 100 Emollivet shares, corresponding…

February 28, 2024

Lipidor AB (publ) publishes year-end report for 2023

STOCKHOLM, Sweden, 28th February 2024 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the…

January 24, 2024

Lipidor completes SEK 1.7 million sale of animal segment patent

STOCKHOLM, Sweden, 24th January 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that one of the company's…

December 21, 2023

Lipidor adds 1.1 MSEK through sale of shares in associated company and agreement of loan

STOCKHOLM, Sweden, 21st December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that 63 shares, corresponding to…

December 20, 2023

Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2

STOCKHOLM, Sweden, 20th December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the company, through its…

December 5, 2023

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 5th December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall…

November 30, 2023

Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)

STOCKHOLM, Sweden, 30th November 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces a change of Certified Adviser…

November 22, 2023

Lipidor AB (publ) publishes interim report for Q3 2023

STOCKHOLM, Sweden, 22nd November 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…